Cargando…
The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421402/ https://www.ncbi.nlm.nih.gov/pubmed/25949371 http://dx.doi.org/10.1093/ndtplus/sfp073 |
_version_ | 1782369861020680192 |
---|---|
author | Sinha, Smeeta Chiu, Diana Y. Y. Peebles, George Kolakkat, Shabeer Lamerton, Elizabeth Fenwick, Sean Kalra, Philip A. |
author_facet | Sinha, Smeeta Chiu, Diana Y. Y. Peebles, George Kolakkat, Shabeer Lamerton, Elizabeth Fenwick, Sean Kalra, Philip A. |
author_sort | Sinha, Smeeta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4421402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44214022015-05-06 The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease Sinha, Smeeta Chiu, Diana Y. Y. Peebles, George Kolakkat, Shabeer Lamerton, Elizabeth Fenwick, Sean Kalra, Philip A. NDT Plus Letter Oxford University Press 2009-10 2009-06-17 /pmc/articles/PMC4421402/ /pubmed/25949371 http://dx.doi.org/10.1093/ndtplus/sfp073 Text en © The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letter Sinha, Smeeta Chiu, Diana Y. Y. Peebles, George Kolakkat, Shabeer Lamerton, Elizabeth Fenwick, Sean Kalra, Philip A. The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease |
title | The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease |
title_full | The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease |
title_fullStr | The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease |
title_full_unstemmed | The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease |
title_short | The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease |
title_sort | safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421402/ https://www.ncbi.nlm.nih.gov/pubmed/25949371 http://dx.doi.org/10.1093/ndtplus/sfp073 |
work_keys_str_mv | AT sinhasmeeta thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT chiudianayy thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT peeblesgeorge thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT kolakkatshabeer thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT lamertonelizabeth thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT fenwicksean thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT kalraphilipa thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT sinhasmeeta safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT chiudianayy safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT peeblesgeorge safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT kolakkatshabeer safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT lamertonelizabeth safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT fenwicksean safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease AT kalraphilipa safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease |